Last reviewed · How we verify

NCT05371587

The Effects of Autonomy and Perceptions on Resistance Training Outcomes

Completed NA Last updated 7 March 2025
What this trial tests

NA trial testing Autonomy and Perceptions Approach to Resistance Training (APART) in Strength Training in 129 participants. Completed in 1 December 2024.

Timeline
1 May 2022
Primary endpoint
30 June 2024
1 December 2024

Quick facts

Lead sponsorTel Aviv University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment129
Start date1 May 2022
Primary completion30 June 2024
Estimated completion1 December 2024
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Tel Aviv University

Who can join

Adults 18 to 45, any sex, with Strength Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

120 participants will be randomized into one of two groups that will perform resistance training at a gym three time per week for three months. One group will follow common resistance training guidelines, whereas the other will exercise according to their preferences and perception of effort. The groups will be compared on the following primary outcomes after six and 12 weeks: body composition, physiological and performance tests. The groups will be compared on the following secondary outcomes every two weeks: enjoyment and satisfaction levels. Adherence rates will be measured throughout the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Strength Training

Currently open trials in the same condition.

Other Tel Aviv University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05371587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing